HomeInsightsStock Comparison

Acutaas Chemicals Ltd vs Lasa Supergenerics Ltd Stock Comparison

Acutaas Chemicals Ltd vs Lasa Supergenerics Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Acutaas Chemicals Ltd is ₹ 1630 as of 18 Dec 15:30.
  • The P/E Ratio of Acutaas Chemicals Ltd changed from 50.6 on March 2022 to 125.9 on March 2025 . This represents a CAGR of 25.59% over 4 yearsThe P/E Ratio of Lasa Supergenerics Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Acutaas Chemicals Ltd changed from ₹ 3642 crore on March 2022 to ₹ 9994 crore on March 2025 . This represents a CAGR of 28.70% over 4 yearsThe Market Cap of Lasa Supergenerics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Acutaas Chemicals Ltd for the Sep '25 is ₹ 316.03 crore as compare to the Jun '25 revenue of ₹ 223.17 crore. This represent the growth of 41.61% The revenue of Lasa Supergenerics Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Acutaas Chemicals Ltd for the Sep '25 is ₹ 105.16 crore as compare to the Jun '25 ebitda of ₹ 66.85 crore. This represent the growth of 57.31% The ebitda of Lasa Supergenerics Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Acutaas Chemicals Ltd changed from ₹ 22.24 crore to ₹ 71.86 crore over 10 quarters. This represents a CAGR of 59.86% The net profit of Lasa Supergenerics Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Acutaas Chemicals Ltd changed from 15.19 % on March 2022 to 7.7 % on March 2025 . This represents a CAGR of -15.62% over 4 yearsThe Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Acutaas Chemicals Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Lasa Supergenerics Ltd

  • Lasa Supergenerics Limited was incorporated on March 11, 2016.
  • The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
  • The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
  • The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
  • It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

Acutaas Chemicals Ltd News Hub

News

Acutaas Chemicals hits record high after reporting strong Q2 numbers

Profit before tax (PBT) soared 92.19% YoY to Rs 96.17 crore in Q2 FY26. In Q2 FY26, EBITDA...

Read more

17 Oct 2025 13:59

News

Acutaas Chemicals to conduct board meeting

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 17 Octob...

Read more

10 Oct 2025 17:08

News

Acutaas Chemicals to convene AGM

Acutaas Chemicals announced that the Annual General Meeting(AGM) of the company will be he...

Read more

03 Sep 2025 15:55

News

Acutaas Chemicals spurts after Q1 PAT surges 199% YoY

In Q1 FY26, Acutaas Chemicals reported a 17.3% rise in consolidated revenue from operation...

Read more

31 Jul 2025 14:23

News

Acutaas Chemicals to discuss results

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 30 July ...

Read more

25 Jul 2025 11:10

News

Baba Advance Materials enters in JV agreement with J & Materials Co.

Baba Advance Materials (BAML), a wholly owned subsidiary company of Acutaas Chemicals has ...

Read more

27 Jun 2025 19:30

Lasa Supergenerics Ltd News Hub

News

Lasa Supergenerics to conduct board meeting

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

06 Nov 2025 16:53

News

Lasa Supergenerics AGM scheduled

Lasa Supergenerics announced that the 10th Annual General Meeting(AGM) of the company will...

Read more

17 Sep 2025 10:01

News

Lasa Supergenerics Ltd leads gainers in 'B' group

Ravinder Heights Ltd, Precision Camshafts Ltd, Salasar Techno Engineering Ltd and JTEKT In...

Read more

09 Sep 2025 12:15

News

Lasa Supergenerics announces board meeting date

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 Augu...

Read more

06 Aug 2025 17:14

News

Lasa Supergenerics to table results

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 26 May ...

Read more

17 May 2025 13:57

News

Lasa Supergenerics to discuss results

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

06 Feb 2025 14:32

SWOT Analysis Of Acutaas Chemicals Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Lasa Supergenerics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Acutaas Chemicals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Lasa Supergenerics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Acutaas Chemicals Ltd and Lasa Supergenerics Ltd

Which company has a larger market capitalization, Acutaas Chemicals Ltd or Lasa Supergenerics Ltd?

Market cap of Acutaas Chemicals Ltd is 13,352 Cr while Market cap of Lasa Supergenerics Ltd is 47 Cr

What are the key factors driving the stock performance of Acutaas Chemicals Ltd and Lasa Supergenerics Ltd?

The stock performance of Acutaas Chemicals Ltd and Lasa Supergenerics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Acutaas Chemicals Ltd and Lasa Supergenerics Ltd?

As of December 18, 2025, the Acutaas Chemicals Ltd stock price is INR ₹1630.95. On the other hand, Lasa Supergenerics Ltd stock price is INR ₹9.47.

How do dividend payouts of Acutaas Chemicals Ltd and Lasa Supergenerics Ltd compare?

To compare the dividend payouts of Acutaas Chemicals Ltd and Lasa Supergenerics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions